Omega Therapeutics, Inc.
OMGA · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$97 | -$103 | -$68 | -$29 |
| Dep. & Amort. | $7 | $5 | $1 | $1 |
| Deferred Tax | $0 | $0 | $1 | $0 |
| Stock-Based Comp. | $9 | $8 | $3 | $1 |
| Change in WC | -$9 | -$10 | $5 | $2 |
| Other Non-Cash | -$0 | $1 | $0 | -$0 |
| Operating Cash Flow | -$92 | -$99 | -$58 | -$26 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$3 | -$1 | -$1 | -$2 |
| Net Acquisitions | $0 | $17 | $0 | $0 |
| Inv. Purchases | -$20 | -$57 | -$39 | $0 |
| Inv. Sales/Matur. | $70 | $41 | $0 | $0 |
| Other Inv. Act. | $1 | -$17 | -$39 | $0 |
| Investing Cash Flow | $48 | -$18 | -$40 | -$2 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $2 | $0 | $8 | $0 |
| Stock Issued | $40 | $1 | $131 | $49 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $1 | $122 | $49 |
| Financing Cash Flow | $42 | $1 | $262 | $49 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$2 | -$116 | $164 | $21 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $71 | $187 | $23 | $3 |
| End Cash | $69 | $71 | $187 | $23 |
| Free Cash Flow | -$94 | -$100 | -$59 | -$28 |